Is Neuronetics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Neuronetics Inc (STIM) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Neuronetics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Neuronetics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Neuronetics Inc?

Muslim investors may consider investing in Neuronetics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Neuronetics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Neuronetics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Neuronetics Inc updated?

The Shariah compliance status of Neuronetics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Neuronetics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Neuronetics Inc?

You can check the latest Shariah compliance status of Neuronetics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

STIM Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 18, 2026

Report Source: 2025 Annual Report

Neuronetics Inc. Stock Analysis STIM

United States Health Care Micro Cap Report: 2025 Annual

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. The company is headquartered in Malvern, Pennsylvania and currently employs 658 full-time employees. The company went IPO on 2018-06-28. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The firm provides more than 7.1 million treatments to over 1,95,000 patients.

Key Statistics of Neuronetics Inc (STIM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.26$1.36

Today's Open

$1.26

Volume

2.49M

P/E Ratio (TTM)

52 Week Range

$0.80$4.85

Market Cap

150.99M

Avg. Volume

2.26M

Dividend Yield

Financial Metrics & Statements of Neuronetics Inc (STIM)

FAQ's for Neuronetics Inc (STIM)

According to Musaffa’s Shariah screening methodology, Neuronetics Inc (STIM) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.